6515--Molecular Pharmacogenomics Equipment and Reagents Cost Per Test

The Department of Veterans Affairs is seeking to procure molecular pharmacogenomics equipment and reagents for the Orlando VA Healthcare System. The scope of this acquisition includes polymerase chain reaction (PCR), next generation sequencing (NGS) testing, and pharmacogenomic testing services provided via a cost-per-test model. This solicitation, identified by number 36C24821Q1573, is being conducted as an unrestricted procurement. Christopher D. Bany serves as the point of contact for this requirement.

The primary classification for this opportunity is NAICS 325413, In-Vitro Diagnostic Substance Manufacturing, and PSC 6515, Medical and Surgical Instruments, Equipment, and Supplies. All responsible sources are permitted to submit an offer by the response deadline of September 10, 2021. Prospective contractors must be registered in the System for Award Management under the appropriate categories to be eligible for award.

Documentation for this requirement includes three attachments: the original solicitation document posted on August 28, 2021, and two subsequent amendments posted on September 2 and September 7, 2021. The notice was published on August 28, 2021, following an anticipated release date on or about August 27, 2021. No specific place of performance or performance period is defined in the notice metadata or description.